HT
GTHX

HAP Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

HAP Trading’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-400,000
Closed -$100K – 906
2024
Q1 		$100K Buy
+400,000
New +$1.39M 0.01% 355
2023
Q1 		– Sell
-31,500
Closed -$17K – 1750
2022
Q4 		$17K Buy
+31,500
New +$264K ﹤0.01% 1001
2022
Q1 		– Sell
-11,800
Closed -$6K – 2898
2021
Q4 		$6K Sell
11,800
-300
-2% -$3.82K ﹤0.01% 2203
2021
Q3 		$2K Sell
12,100
-1,900
-14% -$31K ﹤0.01% 2336
2021
Q2 		$21K Buy
14,000
+2,400
+21% +$53.3K ﹤0.01% 1801
2021
Q1 		$13K Buy
+11,600
New +$270K ﹤0.01% 1587

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return